Open AccessEffectiveness Of 1.2% Simvastatin Gel as an Adjunct to Non-Surgical Therapy in The Treatment of Chronic Periodontitis: A Split Mouth Randomized Controlled Trial
Author(s) -
Neetika Gupta,
Sherry Verma,
Siddharth Sharma,
Jaipreet Singh Gill,
Aman Khurana,
Stuti Gupta,
Tauqeer-Ul-Nisa,
Arushi Dewan
Publication year - 2021
Publication title -
international healthcare research journal
Language(s) - English
Resource type - Journals
ISSN - 2456-8090
DOI - 10.26440/ihrj/0412.03396
Subject(s) - simvastatin , medicine , scaling and root planing , chronic periodontitis , periodontitis , dentistry , placebo , adjunct , randomized controlled trial , bone resorption , gingival and periodontal pocket , surgery , pathology , linguistics , philosophy , alternative medicine
BACKGROUND: Periodontitis is an inflammatory disease that results in bone resorption creating bony defects, which may cause tooth loss. AIM: The present study aimed to evaluate the effectiveness of 1.2% Simvastatin gel as an adjunct to non-surgical therapy to treat chronic periodontitis (CP). MATERIALS AND METHOD: 25 patients with 50 sites were categorized into two treatment groups: Scaling and Root Planing plus 1.2% Simvastatin, and Scaling and Root Planing with placebo. Clinical parameters; site-specific plaque index, modified sulcus bleeding index (mSBI), pocket probing depth (PD), and relative attachment level (RAL) were recorded at baseline, 3, 6, and 9 months. RESULTS: Mean PD reduction and mean RAL gain was found to be greater in Simvastatin group than the placebo group, at 3, 6, and 9 months. CONCLUSION: Locally delivered Simvastatin was found to be effective in the treatment of chronic periodontitis (CP).